Clinical significance of blood‐based miRNAs as diagnostic and prognostic nucleic acid markers in breast cancer: Comparative to conventional tumor markers

Author:

Swellam Menha12ORCID,Ramadan Amal12ORCID,El‐Hussieny Enas A.3,Bakr Noha M.12ORCID,Hassan Naglaa M.4,Sobeih Mohamed Emam5,EzzElArab Lobna R.6

Affiliation:

1. Biochemistry Department Genetic Engineering and Biotechnology Research Division National Research Centre Giza Egypt

2. High Throughput Molecular and Genetic Laboratory Center for Excellence for Advanced Sciences, National Research Centre Giza Egypt

3. Zoology Department Faculty of Science, Ain Shams University Cairo Egypt

4. Clinical Pathology Department National Cancer Institute, Cairo University Cairo Egypt

5. Medical Oncology Department National Cancer Institute, Cairo University Cairo Egypt

6. Clinical Oncology Department Faculty of Medicine, Ain Shams University Cairo Egypt

Funder

Basic and Applied Research Support Grant Project

Capacity Building Grant Project

Publisher

Wiley

Subject

Cell Biology,Molecular Biology,Biochemistry

Reference57 articles.

1. Molecular Profiling of Breast Cancer

2. Treatment of Metastatic Breast Cancer

3. Multidrug‐resistant breast cancer: current perspectives;Martin HL;Breast Cancer (Dove Med Press),2014

4. miR-17-5p promotes the growth of osteosarcoma in a BRCC2-dependent mechanism

5. MicroRNAs in Human Cancer

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3